News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
387,707 Results
Type
Article (31406)
Company Profile (53)
Press Release (356248)
Section
Business (112528)
Career Advice (1313)
Deals (23989)
Drug Delivery (84)
Drug Development (59499)
Employer Resources (102)
FDA (9857)
Job Trends (9053)
News (210958)
Policy (25430)
Tag
Academia (1827)
Alliances (41990)
Alzheimer's disease (952)
Approvals (9790)
Artificial intelligence (77)
Bankruptcy (228)
Best Places to Work (7539)
Biosimilars (50)
Breast cancer (63)
Cancer (623)
Career advice (1103)
Cell therapy (142)
Clinical research (46648)
Collaboration (232)
Compensation (123)
COVID-19 (2413)
Data (547)
Diabetes (100)
Diagnostics (3386)
Drug pricing (75)
Earnings (38759)
Employer resources (93)
Events (44206)
Executive appointments (95)
FDA (10143)
Funding (166)
Gene therapy (113)
GLP-1 (542)
Government (4004)
Healthcare (11353)
Infectious disease (2479)
Inflammatory bowel disease (63)
Interviews (228)
IPO (10278)
Job creations (1743)
Job search strategy (953)
Layoffs (244)
Legal (6990)
Lung cancer (112)
Manufacturing (111)
Medical device (5830)
Medtech (5831)
Mergers & acquisitions (13716)
Metabolic disorders (306)
Neuroscience (1127)
NextGen Class of 2024 (3649)
Non-profit (2755)
Northern California (697)
Obesity (190)
Opinion (167)
Parkinson's disease (54)
Patents (68)
People (24281)
Phase I (14045)
Phase II (20246)
Phase III (16461)
Pipeline (140)
Policy (58)
Postmarket research (1838)
Preclinical (5833)
Radiopharmaceuticals (194)
Rare diseases (126)
Real estate (2572)
Regulatory (15481)
Research institute (1585)
Resumes & cover letters (195)
Southern California (601)
Startups (1876)
United States (6058)
Vaccines (559)
Weight loss (163)
Date
Last 7 days (409)
Last 30 days (1603)
Last 365 days (22926)
2024 (18556)
2023 (25265)
2022 (33395)
2021 (35893)
2020 (34075)
2019 (27911)
2018 (21235)
2017 (20189)
2016 (18692)
2015 (21494)
2014 (15948)
2013 (12876)
2012 (13623)
2011 (14401)
2010 (13078)
Location
Africa (566)
Arizona (63)
Asia (25327)
Australia (4561)
California (1468)
Canada (672)
China (133)
Colorado (62)
Connecticut (58)
Europe (60713)
Florida (212)
Georgia (49)
Illinois (152)
Indiana (103)
Kansas (56)
Maryland (348)
Massachusetts (1077)
Michigan (62)
Minnesota (71)
New Jersey (477)
New York (510)
North Carolina (305)
Northern California (697)
Ohio (66)
Pennsylvania (404)
South America (794)
Southern California (601)
Texas (180)
Washington State (157)
387,707 Results for "biofrontera ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
Biofrontera Inc. today announced the restructuring of agreements between the Company and its former parent company Biofrontera AG.
February 20, 2024
·
5 min read
Regulatory
FDA Action Alert: Biofrontera, BMS and Zealand
One upcoming decision—on a perioperative PD-1 regimen for lung cancer—comes as the FDA considers an overhaul of trial designs in this treatment setting.
September 30, 2024
·
4 min read
·
Tristan Manalac
Genetown
Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp
Biofrontera Inc. (NASDAQ: BFRI), a biopharmaceutical company specializing in the commercialization of dermatologic products, is proud to announce the launch of its FDA-approved RhodoLED XL, a red light emitting LED lamp.
June 24, 2024
·
5 min read
Business
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
Biofrontera Inc., a biopharmaceutical company specializing in the commercialization of dermatologic products, reported financial results for the three months ended March 31, 2024 and provided a business update.
May 15, 2024
·
11 min read
Business
Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference
September 25, 2024
·
1 min read
Business
Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024
Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will report financial results for the three months ended March 29, 2024 on Wednesday, May 15, 2024.
May 6, 2024
·
1 min read
Business
Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
Biofrontera, Inc. today reported financial results for the three and twelve months ended December 31, 2023.
March 15, 2024
·
14 min read
News
Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)
October 14, 2024
·
5 min read
Business
Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules
Biofrontera Inc. (NASDAQ:BFRI) today announced it has entered into a securities purchase agreement with healthcare-focused institutional investors led by Rosalind Advisors.
February 20, 2024
·
7 min read
Genetown
Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules
Biofrontera Inc. announced that it has closed on a securities purchase agreement with healthcare-focused institutional investors led by Rosalind Advisors as of February 22, 2024.
February 23, 2024
·
7 min read
1 of 38,771
Next
